New weight loss pill.

Currently , the U.S. pharmaceutical market has only three main drugs available weight loss : Xenical ( orlistat) , Meridia ( Sibutramine ) and Phentermine . Many obese patients and doctors hope to new and more effective weight loss pills to emerge. Two new weight loss pills that are currently produced and studied in Europe rimonabant ( Acomplia ) and taranabant.

Rimonabant seemed a promising new weight loss pill , but the FDA has begun to worry about serious psychiatric side effects like depression and suicidal tendencies. Taranabant , so far, been less and milder side effects, although both drugs work similarly and comparable new weight loss pill.

The two new weight loss pills affect the receptors in the body system that regulates things like energy levels, food intake , metabolism, and also fear and anxiety. So far, it is unclear why the differences in side effects.

The dose may be a factor. It takes less taranabant to produce similar new weight loss pill. Rimonabant and taranabant also small differences in the way they interact with receptors . It is not clear now why there are fewer side effects in a new weight loss pill and not the other.

Rimonabant or Acomplia , which is already sold in Europe, but it seems that this new weight loss pill will debut in the United States for some time . Merck , the pharmaceutical company taranabant development , it seems that the hope they will be able to file for FDA approval in the summer of 2008. However , no test has been completed and may be a while before this new weight loss pill is available in the United States .

For many obese patients , the hope in the form of a new pill effective weight loss can not come soon enough. t is amazing that all drugs on the market there are only three loss pills available weight approved.

The problem is that the share of obesity that can be controlled by the individual is directly related to human behavior. Part of obesity that can not be controlled is not fully understood.

We were in a dilemma of sorts. If a person is obese due to lack of nutrition and exercise , he or she can help, but only if the person is willing to help themselves . If the person has made ​​a serious attempt to lose weight and can not , it may be a necessary medical intervention. Unfortunately , each new weight loss pill that is produced appears to have potentially dangerous side effects. The FDA can not be blamed for not allowing the sale of drugs like Rimonabant .The duty of the FDA to protect the public against potentially harmful substances. In light of deaths through the use of Fen- phen , the FDA has no reason to be shy of firearms.

Ultimately , science must continue to fight to develop a new weight loss pill to help obese patients otherwise defense, more important, however, have to strain to understand obesity at all levels for new weight loss pill.